Premium
Anti‐HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin
Author(s) -
YAMAMOTO K.,
HONDA T.,
MATSUSHITA T.,
KOJIMA T.,
TAKAMATSU J.
Publication year - 2006
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2006.01761.x
Subject(s) - ribavirin , medicine , clotting factor , factor ix , gastroenterology , hepatitis c virus , hepatitis c , haemophilia , prothrombin complex concentrate , prothrombin time , factor vii , coagulation , surgery , warfarin , immunology , atrial fibrillation , virus